# A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.

> **NCT01286974** · PHASE1 · TERMINATED · sponsor: **Abbott** · enrollment: 3 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** [14C]linifanib
- **DRUG:** ABT-869, linifanib

## Key facts

- **NCT ID:** NCT01286974
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Terminated early, Sponsor Decision
- **Last updated:** 2012-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286974, "A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01286974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*